Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)

(2008) Ingar Holme et al.   ANNALS OF MEDICINE

Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation

(2008) V P van Halm et al.   ANNALS OF THE RHEUMATIC DISEASES

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)

(2008) I. Holme et al.   JOURNAL OF INTERNAL MEDICINE

Early Treatment Reduces the Cardiovascular Risk Factors in Newly Diagnosed Rheumatoid Arthritis Patients

(2008) Athanasios N. Georgiadis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Lipid Profiles in Patients with Rheumatoid Arthritis: Mechanisms and the Impact of Treatment

(2008) George Steiner et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM